Sulfacytine vs. sulfisoxazole for urinary tract infections in an obstetric-gynecologic population.
D000208:Acute Disease; D000328:Adult; D001437:Bacteriuria / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003556:Cystitis / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011776:Pyuria / Q000188:drug therapy; D012008:Recurrence; D013424:Sulfanilamides / Q000009:adverse effects / Q000627:therapeutic use*; D013444:Sulfisoxazole / Q000009:adverse effects / Q000627:therapeutic use*
D013424:Sulfanilamides; D013444:Sulfisoxazole